Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1semaglutideobesitytype 2 diabetesayurveda

Review pairs semaglutide pharmacotherapy with Ayurvedic metabolic frameworks

The authors use Ayurvedic concepts as interpretive analogues, not mechanistic explanations, for weight regain and lean-mass loss after GLP-1 therapy.

MH
By Maren Holt · Senior Reporter, GLP-1

The wire

  1. 01An integrative review in the Journal of Ayurveda and Integrative Medicine uses semaglutide as a case example to discuss weight regain, lean-mass loss and the need for prolonged therapy.
  2. 02Clinicians fielding questions about long-term GLP-1 maintenance may encounter this complementary framing from patients and integrative practitioners.
  3. 03It is a narrative review with no new data, and the authors state Ayurvedic concepts are interpretive rather than mechanistic.

From the source

Long-term metabolic regulation in the era of GLP-1 receptor agonists: An integrative review of Ayurvedic and biomedical perspectives

Journal of Ayurveda and integrative medicine · 2026 Oct 12 · Naikare T, Waghulkar M et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →